Mucins belong to a heterogeneous family of large O-glycoproteins composed of a long peptidic chain called apomucin on which are linked hundreds of oligosaccharidic chains.
Membrane-bound mucin modular domains: from structure to function
Introduction
Mucins belong to a heterogeneous family of large O-glycoproteins composed of a long peptidic chain called apomucin on which are linked hundreds of oligosaccharidic chains.
Based on biochemical and molecular biology studies, mucins were separated into two structurally distinct categories: the secreted and the membrane-bound mucins. Mucins have a cell-and tissue-specific pattern of expression that is profoundly altered in epithelial cancers (loss of expression, over-expression, aberrant expression, neo-expression) suggesting their implication in tumourigenesis [1, 2] . They play roles in cell signalling, cell proliferation, tumour progression or cell polarity, and mediate immune evasion. Mucins are considered as potent new therapeutic targets in mucosal biology, in malignant and inflammatory diseases of the epithelial tissues [3] [4] [5] [6] .
Secreted mucins, gel-forming components of viscoelastic mucus gels protecting the epithelia, include the 11p15 secretory mucins: MUC2, MUC5AC, MUC5B, MUC6. Next to that family of genes, a fifth secretory mucin was described that is MUC19. Their main function is to participate in mucus formation by forming a three-dimensional network via oligomerization domains in order to protect underlying epithelia against various injuries (inflammation, bacteria, virus, pollutants, pH, etc). MUC7 and MUC9 are smaller secreted mucins that do not oligomerize and do not form gels [3, 7] .
The membrane-bound mucins belong to an ever increasing group of type I membraneanchored proteins. Based on their structure and localization at the cell surface they are thought to act in cell-cell and cell-matrix interactions and in cell signalling. The biological roles they play in cellular interactions and in cell signalling indicate that they are involved in regulating biological properties of epithelial cells [4, 5] . Among the membrane-bound mucins, some conform to the mucin definition (presence of a Pro/Thr/Ser (PTS) region in the peptidic sequence) that are MUC1, MUC3A/3B, MUC4, MUC12, MUC16, MUC17, MUC21 and   1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 4 MUC22 [8] [9] [10] [11] . Others were assigned the term MUC despite the absence of that PTS domain that are MUC13, MUC15 and MUC20. Because of their specific pattern of expression during the different steps of carcinogenesis, membrane-bound mucins stay under intense investigation as both potent new biomarkers and therapeutic targets in epithelial cancers [2] [3] [4] .
Analysis of the peptidic sequences of mucins allowed description of their modular organization. Membrane-bound mucins are modular proteins which share conserved domains such as epidermal growth factor-like (EGF) or Sea urchin sperm protein Enterokinase and Agrin (SEA) domains ( Figure 1 ) [8, 9, 12] . The PTS domain, which is a common feature between mucins is the only domain not conserved at the genomic level although similarities exist at the amino acid level. The human MUC1, MUC3A/3B, MUC12, MUC13, MUC16, and MUC17 mucins contain the SEA domains. Some domains are specific to one mucin. For example, the MUC4 mucin contains NIDO, AMOP, and VWF-D domains that are unique in the apomucin family. MUC22 (also called as Panbronchiolitis-related mucin-like protein 1, PBMUCL1) has recently been discovered in the disease-susceptibility locus for diffuse panbronchiolitis and contains both the typical PTS and a transmembrane (TM) domains [10] . Existence of other conserved domains in MUC22 remains to be demonstrated. At this time, MUC15 is considered as a mucin-like since it lacks the characteristic tandem repeat (TR) region.
Understanding the structure and the function of membrane-bound mucin domains will bring new information about their biological roles in epithelium homeostasis as well as in pathological situations such as carcinogenesis or inflammatory processes in which membranebound mucin expression and localization are often altered. In this review, we will discuss the structural and functional features of the evolutionary conserved domains of membranebound mucins and their abilities to modulate the biological properties of epithelial cells. 3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 5
Mucins and evolution
Phylogenetic analyses have shown that the membrane-bound mucins are only found in mammals with the exception of MUC16 and MUC4 [13] . Mucin domains are shared among most of the MUC family members, suggesting common ancestors or adoption of functional modules during evolution. MUC1, MUC3, MUC12, MUC13 and MUC17 share a peptidic sequence similar to heparan sulfate proteoglycan of basement membrane (HSPG2) ( Figure   2 ). MUC3, MUC12 and MUC17 genes are present contiguously on chromosome 7 (7q22) supporting the hypothesis of a process of duplication. MUC16 evolved separately from agrin.
MUC4 arose from two evolutionary events involving (i) NIDO and EGF-like domains from a common ancestor to nidogen and (ii) AMOP and VWF-D domains from a common ancestor to the Susd2 [13] . Beside its homology through the SEA domain, MUC1 has sequence similarities with other membrane-bound mucins and in fact evolved from repeated sequences of MUC5B secreted mucin [14] . Based on available sequence information, one can hypothesize that membrane-bound mucins evolved from several distinct ancestor genes and could be divided in different subgroups based on their conserved domains. Interestingly, mucins arising from a common ancestor gene are frequently clustered in a chromosome locus as illustrated on figure 2.
The membrane-bound mucin prototype domains
A prototype membrane-bound mucin is characterized by the presence of an extracellular Oglycosylated PTS domain, a TM domain and a cytoplasmic tail. Two EGF-like and one SEA domains are commonly found in most of membrane-bound mucins ( Figure 1A ). 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 6 The hallmark of membrane-bound mucins is the large extracellular subunit that protudes at the cell surface mainly composed by the PTS domain. The PTS domain is the substrate of important post-translational O-glycosylation modifications. This central domain is encoded by a large intronless genomic DNA sequence (>10 kb), typically characterized by a variable number of tandem repeat (VNTR) polymorphism [15] . PTS domain harbours extensive Oglycosylation (up to 80% of the total weight of the mature mucin) that forms chains of varying lengths, sequences, and compositions. The biosynthesis of mucin O-glycan chains is a step-by-step process occurring in the Golgi apparatus, involving specific glycosyl-and sulfotransferases expressed in a tissue-specific manner [16, 17] . The O-glycans on PTS domain play major roles in the conformation and stability of the mucin and participate in defense of mucosae covering and protecting the underlying epithelium against various types of aggression (mechanical and chemical stress). In diseases such as cancer and inflammation, mucin O-glycosylation is altered, modifying the antigenic and adhesive properties of the glycan epitopes they bear [18] . Tumour-associated carbohydrate antigens (TAAs) are produced via incomplete synthesis of carbohydrate chains. TAA notably involve Tn and T antigens and their sialylated counterparts, sialyl-Tn and sialyl-T antigens. Cancer-associated O-glycans are often highly sialylated and less sulfated compared with O-glycans from normal mucins [19, 20] .
1 The PTS domain
Because of its extracellular localization at the apical pole of the cell, the MUC PTS domain is mainly thought to act as a sensor of the microenvironment. In the normal polarized epithelial cell, it may interact with immune cells, antibodies, viruses, bacteria to help maintain the epithelial homeostasis. In a depolarized cancer cell, the membrane-bound mucin is then expressed circumferentially and is going to then play different roles in cell-cell or cell-extracellular matrix interactions. For example, the MUC1 PTS domain is able to interact with adhesion molecules such as the endothelial protein ICAM-1 and Membrane-bound mucin modular domains: from structure to function 7 consequently may assist the cancer cell during heterotopic adhesion and invasion into the endothelium and reattachment at distant metastasis sites [21, 22] .
Galectins belong to a family of carbohydrate binding proteins (-galactoside-specific lectins).
Galectin-1 was shown to interact with MUC16. Galectin-3 interacts with MUC1, MUC4 and MUC16. O-glycans on MUC4 PTS interact with galectin-3 at the cell surface and mediate docking of tumour cells on endothelial cells [22, 23] . Galectin-3-MUC1 interaction alters MUC1 cell surface polarization, enhances tumour cell homotypic aggregation, prevents anoikis [24, 25] , and regulates EGFR internalization, subcellular localization and ERK signalling pathway activation [26] .
2 The epidermal growth factor (EGF)-like domain
EGF-like domains are 30-40 residue-long and evolutionarily well-conserved. The EGF-like domain contains six cysteine residues that form three different disulfide bonds within the domain (C1-C3, C2-C4, and C5-C6). The first cysteine exhibits a mild conservation between the different mucins whereas the five others are highly conserved suggesting that the resulting tertiary structure leads to biological functions ( Figure 3A /3B).
The EGF-like domains of membrane-bound mucins are believed to direct the interactions with different proteins. Mucin EGF-like domains are thought to act as ligands with membrane receptor such as those of the ErbB family mostly based on the work conducted on MUC4/rMuc4 biological roles. It has been speculated that EGF domains located in the released extracellular domain of mucins resulting from cleavage could also act as growth factors and serve as indicators of alteration of epithelial surfaces [5] .
Experimental evidence suggests that rat homologues of Muc4 and ErbB2 are regulators of signalling related to growth, motility or differentiation of the cell via the EGF-like domains [27] . Human MUC4 and ErbB2 were shown to physically interact via a peptidic region 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 8 including the three EGF-like and intermediate domains of MUC4 [28] . Recombinant human MUC3A TM-EGF1/EGF2 protein led to reduced apoptosis induced either by TNF-α or Fas receptor stimulation. MUC17 EGF-like domains (also designated as Cys-rich domains, CRD) were shown to have anti-apoptotic and pro-migratory activity via ERK phosphorylation but did not stimulate cell proliferation [29, 30] . In vivo rectally administered MUC17 CRD, as well as its mouse homologue, accelerated healing in an experimental mouse model of colitis [29] , suggesting a potential therapeutic use of EGF-like domains as treatment of mucosal inflammatory diseases.
The deduced amino-acid (aa) sequences of the EGF-like domains of MUC4, MUC3A, MUC12, MUC13, MUC16 and MUC17 (Table1) were used to predict their 3D structures using the Phyre 2 server (Protein Homology/analogy Recognition Engine V2.0) [31] . The Membrane-bound mucin modular domains: from structure to function 9 below 1.5Å, two 3D structures whose sequence alignment is over 30% can be considered as almost homologous. The most significant result is then correlated with the highest number of residues aligned. Regarding the mucin EGF domains, there is strong structural homology between the 3D structure of the human EGF and the 3D predicted structure of MUC4 EGF1 , MUC3A EGF and MUC13 EGF1 (Table 1) . We also found high homology between MUC13 EGF1
and MUC3A EGF and MUC12 EGF . The 3D predicted structure of MUC4 EGF1 was shown to be homologous to MUC16 EGF .
3 The Sea urchin sperm protein Enterokinase and Agrin (SEA)
The SEA module is a 120 aa domain found in many membrane-associated proteins at the cell surface. SEA domains were initially described as extracellular domains associated with Oglycosylation but more recently they have also been implicated in both cleavage events and association of the subunits [32] [33] [34] . Mucins usually contain one SEA domain in their extracellular region. However, MUC16 contains multiple SEA domains that were repeated up to 56 times through duplication events [13] . Alignment analysis indicated a mild conservation of the SEA domains of the different membrane-bound mucins ( Figure 3C ). We confirmed that MUC3, MUC12 and MUC17, that are located in a cluster on the human 7q22 chromosome, share the highest identity of SEA sequences ( Figure 3D ).
The MUC1 SEA module is a self-cleaving domain [35] . Computer moduling of MUC1 SEA domain initially suggested that it consists in three -helixes and six -strands forming an / sandwich fold [33] . Macao et al. later determined that SEA consists of four-stranded antiparallel -sheets and four -helixes occurring in the 1-1-2-2↑3-3-4-4 order and with the helixes packed against the concave surface of the -sheet [35] . Moreover, determination of the SEA domain structure from the murine Muc16 homologue using multidimensional NMR spectroscopy allowed Maeda et al. [36] to propose the GSVVV motif as a 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function proteolytic cleavage site located in the short loop connecting 2 and 3 sheets. Levitin et al. proposed that this module likely functions as a site for proteolytic cleavage in all SEA module-containing proteins [37] . Cleavage of membrane-bound mucins in the SEA domain is not entirely sequence dependent, but may be related to structural features of the SEA domain.
Exposure of the cleavage site protruding outward from a compact structure enhances its recognition and cleavage by cellular proteases [33] . In addition to its cleavage involvement, MUC17 EGF1-linker-EGF2 recombinant protein induces anti-apoptotic activity that requires an intact SEA module [29] .
The deduced aa sequences of the SEA domains of MUC1, MUC3A, MUC12, MUC13, MUC16 and MUC17 (Table 2) were used to predict their 3D structures using the Phyre 2 server. The 3D predicted structures of each SEA domain was compared with the 3D resolved structure of the human mucin MUC1 available in the protein data bank (pdb code : 2ACM) and with the 3D predicted structures of the other SEA domains using the molecular visualization system, PyMOL. In the same manner and with the same criteria as for the 3D Figure 4B ) [33] .
The unique domains of membrane-bound mucin MUC4
Among membrane-bound mucins, MUC4 contains NIDO, AMOP, and VWF-D domains that are unique in the apomucin family. protease-independent cell invasion in pancreatic cancer metastasis [38] .
2 The Adhesion-associated domain in MUC4 and Other Proteins (AMOP)
AMOP and vWF-D domains originated from a common ancestor to the Sushi-domain containing protein 2 (SUSD2) [13] . AMOP domain is uncommon in the human genome as it is described only in four proteins (Isthmin-1, -2, SUSD2 and MUC4) using Simple Modular Architecture Research Tool (SMART) database. The role of AMOP domain is unclear.
Presence of AMOP in cell adhesion molecules could be indicative of a role for this domain in adhesion. Indeed, mouse Isthmin, an angiogenesis modulator, disrupts endothelial cell (EC) capillary network formation on Matrigel through its C-terminal AMOP domain [40] . From there, one could hypothesize such role for MUC4 in angiogenesis. Membrane-bound mucin modular domains: from structure to function
3 The Von Wildebrand Factor-D (vWF-D) domain
The human gel-forming mucins contain vWF-D and C-terminal cysteine-knot domains that are responsible for their oligomerization [9, 41, 42] . Only MUC4 membrane-bound mucin contains a vWF-D in its intracellular region [9] . VWF domains usually participate in forming disulfide bonds. However, the cysteine residues, conserved in secreted mucins, are not conserved in MUC4 suggesting a loss of function of this domain in membrane-bound mucins during evolution [43] . The crystal structures of three vWF domains are known. All three domains share identical three-dimensional fold with a α-β-α sandwiched model [44] .
The cytoplasmic tail
Cytoplasmic tails (CT) of mucins are poorly conserved ruling out a potential common evolution. Size and aa sequence greatly vary among membrane-bound mucins leading to a great variety of functions in cell signalling (Table 3) . Indeed, MUC4 acts as a receptor partner at the membrane through its extracellular domain because of its short CT whereas MUC1 acts as an intracellular docking protein for signalling molecules. Among membrane-bound mucins, MUC1 has been under intense investigation.
MUC1 CT , is 72 aa long, contains seven tyrosine residues, an Src Homology 2 (SH2) interaction domain, and is phosphorylated by several kinases [4, 22, 45, 46] . The MUC1 CT allows the direct interaction of MUC1 with a wide array of signalling pathways in tumour cells. MUC1 CT was shown to interact with Src family kinase including c-Src, Lyn and Lck and promotes phosphorylation of Tyr46 involved in protein-protein interaction. MUC1 CT is also targeted by kinases  chain associated protein kinase of 70 kDa (ZAP70), and the  isoform of protein kinase C (PKC) [22, 47] . Interaction between MUC1 CT and proapoptotic kinase cAbl leads to phosphorylation of Tyr60 by its binding to the c-Abl SH2 domain [48] .
Binding of scaffolding protein Grb2 on MUC1 CT activates MAPK pathway, involved in 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 13 proliferation of tumour cells [49] . MUC1 CT interacts with components of the IB kinase (IKK) complex enhancing IKK-IKK interaction, promoting IKK phosphorylation, IKK degradation, NFB-p65 targeting to the nucleus that leads to NF-B p65 transcriptional activity [50, 51] . MUC1 CT interacts with chaperone heat shock proteins (HSP) HSP70 and HSP90 leading to mitochondrial translocation of MUC1 CT and therefore inhibiting apoptosis [52] . MUC1 CT binds to Wnt signalling pathway components -catenin and APC. MUC1 CT --catenin interaction enhances the levels of nuclear -catenin during disruption of cadherinmediated cell-cell adhesion and promotes expression of Wnt target genes [46, 53] . The MUC1 CT --catenin binding is regulated by GSK3 and HSP90 in a competitive inhibition manner [54] . MUC1 CT is phosphorylated by several cell surface receptors such as fibroblast growth factor receptor 3 (FGFR3), platelet-derived growth factor receptor (PDGFR) and ErbB receptor family altering interaction with proteins mentioned above. FGF1 induces Tyr46
YEKV phosphorylation whereas PDGF catalyses phosphorylation of Tyr35 and enhances invasion in vitro, tumour growth and metastasis in vivo [55] .
MUC1 CT also regulates its own nucleo-cytoplasmic transport by binding importin- and nucleoporin p62 (nup62) via a CQC motif and therefore alters transcriptional regulation of numerous target genes [56] . In the cytoplasm of breast and lung cancer cells, MUC1 CT forms dimers that are necessary for its nuclear localization via the CQC motif [56, 57] . In the nucleus, MUC1 CT associates with transcription factors such as -catenin/TCF4, p53, CDKN1A (p21), nuclear factor-B p65 or STATs [3] . The MUC1 CT domain also stabilizes estrogen receptor- (ER) and is necessary for its nuclear localization [58] .
MUC1 CT has been extensively characterised whereas other mucin CT are scarcely described.
MUC3 CT contains an YVAL aa motif which is similar to motifs recognized by the SH2 domain [59] . MUC13 CT contains a PKC phosphorylation site [60] . MUC16 CT contains polybasic aa that are predicted to interact with ezrin/radixin/moesin (ERM) actin-binding 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 14 proteins [61] and is proposed to cross-link MUC16 with actin-cytoskeleton. MUC16 CT is also proposed to interact with JAK2 via its ERM domain and mediate breast cancer cell proliferation [62] . PDZ-interacting domains are observed within MUC3 CT , MUC12 CT and MUC17 CT but only phosphorylation sites of MUC17 CT exhibit a strong binding to PDZ domain of PDZK1 [63] . It was also shown using Pdzk1 -/-mice that Pdzk1 plays a specific role in stabilizing mMuc3 (MUC17 mouse homologue) at the apical pole of polarized enterocytes.
MUC20 CT binds to a multifunctional docking site of hepatocyte growth factor (HGF) receptor
Met and therefore suppresses the Grb2-Ras pathway [64] .
The tremendous variability of MUC CT is thus associated with a wide array of signalling pathways regulated by membrane-bound mucins and much is still to be discovered to fully characterize their biological activities and effects on epithelial cell behavior.
Mucin splice variants

1. MUC1
Membrane-bound mucin isoforms or alternative splicing events have been reported for mouse mammary epithelial cells [65] . An alternate isoform MUC1/ZD results from a reading 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function 15 frameshift caused by a splicing event that deletes the TR-PTS domain but contains the signal peptide and a subsequent stretch of 30 aa [66] . Variant MUC1/SEC lacks the TM and cytoplasmic sequences and has the potential to be directly secreted out of the cell. 
MUC4
Multiple splicing events have been described for MUC4 [69] . Among them, MUC4/Y and MUC4/X lack the central TR/MUC4 PTS domain, the main feature of membrane-bound mucins [69] . Some MUC4 isoforms are also lacking TM domain and might be secreted. One could hypothesize that the EGF-like domains of MUC4 act as growth factors when released in the extracellular environment. Globally, more than twenty cDNA isoforms have been described for MUC4 that are generated by several mechanisms (alternative use of cassette exons, exon skipping or use of cryptic splice donor/acceptor sites) [70] . However, till now no splice variants for Muc4 have been observed in mouse tissues [9] . So far, the existence at the protein level and the biological roles of the different MUC4 isoforms remain to be determined.
3. Other mucin variants
Transcription variants of MUC3 encode truncated proteins, suggesting the possibility of expression of soluble forms [71] . Williams et al. confirmed the existence of two secreted 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 Membrane-bound mucin modular domains: from structure to function isoforms of MUC3 that lack the TM domain [72] . In a similar manner, an alternative MUC17 splice event occurs and lacks the second EGF domain, the TM domain, and the cytoplasmic tail and leads to a secreted form MUC17/SEC [73] .
Using MUC domains as therapeutic targets/tools
Membrane-bound mucins display major biological activities in epithelium homeostasis and pathologies and hold promise as biological tools for therapy in cancer or inflammatory diseases [4] . [75] . Moreover, PMIP selectively inhibits lung adenocarcinoma proliferation, and inhibits ER responses via the blocking of the MUC1-ER interaction [76] . MUC1 CT dimerization may also be targeted by reducing agents. Similarly, cell-penetrating peptide containing the CQCRRKN sequence binds directly to the endogenous MUC1 CT and blocks its ability to dimerize [57] . That blockage induces death of human breast cancer cells in vitro and in xenograft tumour models [77] .
Since MUC1 displays ubiquitous expression in a wide variety of tumour types, numerous studies are targeting MUC1. The MUC1 peptide core or glycopeptide has been used in immunotherapy for immunization. The different strategies showed T cell-and antibodyresponses and then were challenged for tumour protection [78, 79] . Recently, immunization 1  2  3  4  5  6  7  8  9  10  11  12  13  14  15  16  17  18  19  20  21  22  23  24  25  26  27  28  29  30  31  32  33  34  35  36  37  38  39  40  41  42  43  44  45  46  47  48  49  50  51  52  53  54  55  56  57  58  59  60  61  62  63  64  65 by a tripartite vaccine based on a synthetic 60-mer MUC1 PTS derived peptide covalently linked to a Toll-like receptor (TLR) agonist could elicit IgG antibodies that efficiently lysed MUC1-expressing cancer cells, stimulated cytotoxicity of T lymphocytes, and activated innate immune responses [80] .
Trastuzumab (also called herceptin®), a monoclonal antibody, targets ErbB2-expressing tumours such as breast cancers and leads to inhibition of intracellular signalling and induction of an immune system-mediated antitumour response [81] . Human MUC4 and ErbB2 do physically interact via MUC4 EGF3+1+2 region that contains the three EGF-like domains [28] .
MUC4 overexpression decreases cancer cell sensitivity to trastuzumab, possibly by steric hindrance [82] . MUC4 is thought to impair access of trastuzumab to ErbB2 via its large PTS domain that protrudes outside the glycocalyx. More recently, we also showed an effect of MUC4 on gemcitabine sensitivity in pancreatic ductal adenocarcinoma [83] but via domains and partner still to identify.
MUC17 EGF domains display a strong potential in the treatment of mucosal inflammatory diseases as healing is accelerated in acetic acid and dextran sodium sulfate (DSS)-induced colitis in mice [29] . MUC1 also has a protective effect against DSS-induced colitis in mice.
Since Muc1 is lacking EGF-like domains, this effect is most likely mediated by another mechanism. MUC1 could act through its ability to increase the mucus barrier but also by decreasing T cell recruitment to the afflicted site [84] .
Conclusions
Membrane-bound mucins are characterized by a multi-domain organisation with a PTS domain, conserved EGF or SEA domains and unique domains such as AMOP, NIDO or vWF-D that could mediate specific functions for some membrane-bound mucins.
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